Skip to main content

Table 2 Efficacy outcomes (per protocol analysis) on days 14 and 28

From: Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up

Day 14 AM-L AS+AQ
ACPR 100 107
ETF 0 0
LCF 1 0
LPF 2 2
Day 28   
ACPR 97 102
ETF 0 0
LCF 3 1
LPF 3 4
  1. AM-L = artemether-lumefantrine, AS+AQ = artesunate+amodiaquine
  2. Day 28 cure rates are cumulative figures from day 14. ACPR = adequate clinical and parasitological response, ETF = early treatment failure, LCF = late clinical failure, LPF = late parasitological failure